Connect with us

Media OutReach

Amaris B. Clinic 2026 Forecast: Corrective & Restorative Procedures Demand Increases to Address Post-GLP-1 Weight Loss Aesthetic Concerns

Published

on

The clinic identifies a significant shift from aesthetic enhancement to comprehensive restoration, driven by the physical consequences of rapid weight reduction.

SINGAPORE – Media OutReach Newswire – 9 December 2025 – The widespread use of GLP-1 medications for weight management is driving a fundamental turn in patient needs within medical aesthetics.

Dr Ivan Puah, Medical Director of Amaris B. Clinic and Chairman of Singapore’s Lipo Peer Review Committee, draws from a decade of clinical practice data, “We are observing a distinct and growing patient cohort. After achieving significant weight loss, individuals are presenting with common aesthetic concerns, including pronounced skin laxity, facial volume depletion, hair thinning and disproportionate fat distribution. This is creating a definitive demand for integrated treatment strategies that address these changes.”

This change redefines the role of aesthetic medicine within holistic wellness. Dr Puah’s 2026 forecast details the key trends.

1. The Rise of Post-Weight-Loss Body Contouring, Enhancement & Tightening

A marked increase in consultations for body reshaping following substantial weight loss is evident. Common concerns such as loss of breast volume and stubborn fat on the arms and thighs are fuelling demand for combined solutions.

“The approach is necessarily multifaceted,” states Dr Puah. “This can involve modern liposuction for natural-looking body contouring and autologous breast fat grafting.”

2. Facial Reflation & Rejuvenation

The rapid facial volume loss associated with GLP-1 use creates a unique clinical challenge, often accelerating skin ageing regardless of a patient’s chronological age.

“We are seeing a simultaneous deflation across the entire face, such as the temples, cheeks, and jawline, which requires a fundamental shift in approach,” explains Dr Puah.

The solution lies in ‘facial reflation’: a tailored strategy to rebuild the skin’s foundational support through facial fat grafting, collagen-regenerating injectables, and energy-based technologies for a natural, lasting restoration.

3. Prejuvenation: Long-Term Structural Resilience Investment

Patients in their early 30s and 40s are increasingly seeking to preserve skin integrity before changes begin. “The goal is evolving from repairing visible ageing to strategically strengthening the skin’s natural support system before major volume or elasticity loss occurs,” explains Dr Puah.

“Demand is growing for biostimulatory injectables and non-invasive modalities like microfocused ultrasound, which work at a foundational level to stimulate collagen and promote sustained firmness. This is proactive aesthetics in action and is a strategic investment in the skin’s architecture.”

4. Beyond Hair Growth: Tech-Integrated Hair Therapy

Stress, the natural ageing process, and increased attention to hair thinning in the context of GLP-1 use have accelerated demand for effective, non-surgical solutions.

“We are moving past generic treatments. Personalised dual-action protocols, such as combining radiofrequency microneedling with exosome therapy, will remain in demand. This non-invasive, no-downtime treatment not only stimulates follicle regeneration but also increases hair density and boosts collagen and elastin, which are essential for healthy hair and scalp.

As we head into 2026 and beyond, it is clear that medical aesthetics is no longer just about enhancement. We are not just treating concerns; it’s about tailored restoration. Our approach must be as dynamic as their needs,” says Dr Ivan Puah.

For more information, visit www.amaris-b.com

Statistics & Clinical References

  • Goldman Sachs Global Investment Research. (2023). The GLP-1 Wave: A $100B Market in the Making.
  • Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Kushner, R. F. (2021). Once-weekly Semaglutide In Adults With Overweight Or Obesity. New England Journal Of Medicine, 384(11), 989-1002.
  • American Academy of Dermatology (AAD). (2023). Public Awareness And Dermatologist Observations On Facial Aging Associated With Rapid Weight Loss.
  • American Society of Plastic Surgeons (ASPS). (2022). Plastic Surgery Statistics Report.
  • Fruhstorfer, B. H., & Malata, C. M. (2003). A Systematic Approach To The Surgical Treatment Of Gynaecomastia. British Journal Of Plastic Surgery, 56(3), 237-246.
  • Grand View Research. (2023). Dermal Fillers Market Size, Share & Trends Analysis Report.
  • Fitzgerald, R., & Vleggaar, D. (2018). Poly-L-lactic acid for soft tissue augmentation: a retrospective European study of 195 patients. Journal of Drugs in Dermatology, 17(1), 83-88.
  • Jeong, K. H., et al. (2020). Fractional Radiofrequency Microneedling For The Treatment Of Androgenetic Alopecia: A Prospective, Randomized, Comparative Study. Dermatologic Surgery, 46(10), 1304-1310.
  • Global Hair Loss Treatment Market Analysis (2023-2030). Market Research Future (MRFR).
  • Suh, D. H., et al. (2016). A Prospective Study Of The Safety And Efficacy Of A Microfocused Ultrasound With Visualization For Non-invasive Body Contouring. Journal Of The American Academy Of Dermatology, 75(4), 697-704.

Hashtag: #AmarisB.Clinic






The issuer is solely responsible for the content of this announcement.

ABOUT AMARIS B. CLINIC & DR IVAN PUAH

ABOUT AMARIS B. CLINIC

Amaris B. Clinic, established in 2004 in Singapore and led by Dr Ivan Puah, focusing on medical aesthetics and cosmetic surgery.

The clinic offers facial and body sculpting services such as liposuction, gynecomastia surgery, and fat grafting, as well as non-surgical treatments like Ultherapy Prime, biostimulator injections, and hair loss therapy.

ABOUT DR IVAN PUAH

Dr Puah, an MOH-accredited liposuction doctor with extensive training in various cosmetic procedures, is committed to providing personalised care with an artful eye and proven medical techniques.

  • Chairman of the Lipo Peer Review Committee in Singapore
  • Trained in Vaser liposuction (fundamental and hi-definition) in Colorado and Argentina
  • Dedicated surgical training in gynecomastia surgery in San Francisco
  • Trained in syringe liposculpture, fat grafting, and thread lift from renowned French plastic surgeon, Dr Pierre Francois Fournier
  • Appointed trainer by Allergan and Merz for fellow doctors on cosmetic injectables
  • Designated trainer for PDO thread lift and Picolaser from Venusys Medical
  • Graduate Diploma in Family Dermatology from NUS
  • Graduate Diploma in Acupuncture from TCMB
  • Graduate Diploma in Sports Medicine from LKCMedicine, NTU

Advertisement

Media OutReach

From PolyU Research to Geneva Global Debut: GOOD Vision oka³y! ™ Redefines Precision in Freeform Orthokeratology

Published

on

GENEVA, SWITZERLAND – Media OutReach Newswire – 9 March 2026 – GOOD Vision Technologies Co., Limited, a pioneer in ophthalmic optics and diagnostics, today announced the global debut of oka³y!™, a first-of-its-kind “3A” Freeform Orthokeratology (Ortho-K) solution. Unveiled at the 51st International Exhibition of Inventions in Geneva, the technology solves the industry’s most persistent hurdles by leveraging proprietary AI and freeform optics: AI-guided fitting, Astigmatic precision, and Asymmetric cornea alignment.

Beyond Traditional Toric Lenses: The Future of Freeform Orthokeratology

With myopia expected to affect 50% of the world’s population by 2050, demand for effective management is high. While Ortho-K is a highly effective strategy, traditional symmetric and spherical/ toric designs often underestimate corneal shape complexity, causing lens decentration and poor visual outcomes.

The oka³y!™ freeform technology, incorporating the company’s proprietary FAST-360 and CORe Technology, surpasses traditional lens design. AI-based FAST-360 reconstructs missing corneal data for faster scans, while CORe ensures precise alignment with the visual axis, leading to 3.1 times greater stability.

Precision Myopia Correction and Control for High Astigmatism and Asymmetric Corneas

For optometrists and clinic owners, oka³y!™’s key benefit is improving workflow by automating complex mathematics, cutting chair time by 64%. This boosts myopia management capacity without extra staff or lengthy training. “As a registered optometrist in Hong Kong and a researcher in one of the world’s leading optometric institutes, I witnessed a growing gap between the number of patients seeking Ortho-K and the limited range of conventional products available to treat them,” says Dr. Kin Ho Chan, Ken, the lead inventor of oka³y!™. “By focusing on the ‘3A’: AI-guided, Astigmatism, and Asymmetry, and working alongside The Hong Kong Polytechnic University (Poly U), we have developed a design that not only delivers superior vision but also enhances safety by reducing corneal staining. We are turning a frustrating, manual trial-and-error process into a predictable one-click adjustment.”

From Niche Specialty to Global Enterprise: Scaling the Future of Eye Care

As myopia rates reach epidemic levels, GOOD Vision partners with PolyU, harnessing its research strengths and support from its startup ecosystem PolyVentures, to redefine primary eye care by transforming a niche specialty into a scalable global enterprise. By replacing manual OK lens design with oka³y!™, the company has created a technology bridging clinical complexity and scalability. This transition enables practitioners to manage myopia, high astigmatism, and asymmetrical cases precisely, removing barriers to modern refractive error management.

“By embedding and automating the complex mathematics of lens design, we provide clinicians with the tools to treat ‘difficult’ patients who were previously considered unsuitable for Ortho-K,” added Professor Chea-su Kee, Founder of GOOD Vision. “This is about elevating the global standard of care and ensuring that precision myopia management is accessible to the next generation on a global scale.”

Experience the Future of Myopia Control

GOOD Vision invites investors, distributors, and practitioners to a live demonstration of the oka³y!™ at the International Exhibition of Inventions Geneva:

  • Location: PolyU Delegation Booth, Hall 2, Palexpo, CP 112, Route François-Peyrot 30, 1218 Le Grand-Saconnex, Geneva, Switzerland
  • Dates: 11–15 March 2026

Hashtag: #GOODVision

The issuer is solely responsible for the content of this announcement.

About GOOD Vision Technologies Co., Limited

GOOD Vision, a Hong Kong-based startup nurtured by PolyU, is dedicated to advancing the field of corneal reshaping technologies. With a focus on innovation, efficiency, and affordability, the company develops innovative solutions to empower eye practitioners and enhance the quality of eye care worldwide.

For additional details about GOOD Vision and their innovative offerings, please visit

Continue Reading

Media OutReach

Tech Innovator Acquires Nexxus Building Trivium to Oversee Asset Management

Published

on

Central Landmark Set for Revitalization with International Expertise

HONG KONG SAR – Media OutReach Newswire – 9 March 2026 – In a vote of confidence in Hong Kong’s vibrant and enduring business environment, Nexxus Building, a landmark Grade‑A commercial property in Central’s prestigious CBD, has been acquired by a leading figure in the technology sector. Trivium Asset Management (“Trivium”), an Asian real estate investment and asset management firm, has been appointed as Nexxus Building’s Asset Manager (“AMC” or Asset Management Company), taking charge of the asset’s comprehensive management and operations.

Under new ownership, Nexxus Building is set to undergo a forward‑looking transformation integrating next‑generation technologies with world‑class professional management. The revitalization aims to redefine the building’s market positioning, enhance its tenant experience, and reinforce its status as an iconic and premier Grade‑A property in the heart of Hong Kong’s CBD.

Leveraging Trivium’s extensive expertise, the enhancement programme will incorporate smart‑building management systems and sustainability‑driven upgrades designed to meet the evolving needs of global tenants. The reimagined Nexxus Building aims to attract financial institutions, fintech platforms, and technology enterprises, reaffirming Central’s position as Asia’s dynamic financial and innovation hub.

Mr. Wilfred Ma, Managing Partner of Trivium Asset Management, said, “Trivium is honored to be entrusted with the role of Asset Manager (“AMC” or Asset Management Company) for Nexxus Building, one of Hong Kong’s most iconic commercial landmarks. Drawing on our track record in real estate investment and operations across Hong Kong and Japan, we are committed to implementing forward‑thinking strategies that enhance tenant value, optimize building performance, and unlock Nexxus Building’s full potential as a commercial anchor in the city’s core.”

Originally built in 1962 as the former headquarters of Hang Seng Bank, Nexxus Building has been a witness to Hong Kong’s rise as a global financial centre. Following a major renovation in 2008 and the addition of a direct footbridge to IFC and the Airport Express in 2020, the building continues to host multinational corporations, leading financial institutions and professional services firms, and premium retail tenants – including the iconic Hong Kong Bankers Club – reinforcing its status as one of Central’s most distinguished Grade‑A office towers.

Hashtag: #TriviumAssetManagement

The issuer is solely responsible for the content of this announcement.

About Trivium Asset Management

Founded in 2022, Trivium Asset Management is a Hong Kong‑based real estate investment and asset management firm overseeing assets valued at over US$900 million across Asia. Trivium serves institutional investors, financial institutions, and family offices through integrated investment and asset management, value‑creation strategies, and technology integration. The firm’s mission is to maximize long‑term value and promote sustainable growth for clients and communities alike.

Continue Reading

Media OutReach

HOFA Announces the Second Edition of the Digital Art Awards, in Collaboration with Exhibition Partner PhillipsX in Hong Kong, proudly backed by Lightyear

Published

on

HONG KONG SAR – Media OutReach Newswire – 9 March 2026 – Celebrating a new generation of digital artists working across generative systems, AI, immersive media and experimental formats, with winners selected by a panel of leading experts and exhibited at Phillips’ Asia headquarters in the West Kowloon Cultural District during Hong Kong Art Basel Week 2026.

Refik Anadol, ‘Sense of Healing’, 2023, AI Data Sculpture (Courtesy of the Artist)

The awards ceremony will take place on 24 March 2026, featuring the four key categories of Still Image, Moving Image, Innovation and Experiential and followed by a private sale exhibition hosted by Phillips in Hong Kong, from 25–28 March 2026.

As a highlight of Hong Kong’s spring art calendar, the awards celebrate the growing cultural significance of digital art and spotlights the visionary artists redefining visual culture through cutting-edge technologies.

Thirty two international finalists will be selected for their work pushing the boundaries of digital creativity. Each of the four category winners will receive a $10,000 USDC commission towards a new artwork.

The thirty two finalists include several prominent figures in digital and generative art, such as Erick Calderon (Snowfro) Founder of Art Blocks, Botto, Sarah Meyohas, William Mapan, Sasha Stiles and Mario Klingemann – underscoring the calibre of talent the awards are already attracting with over two hundred applications across more than fifty countries.

Refik Anadol is nominated for the Honorary Career Award for Sense of Healing, an AI Data Sculpture that emerges from Refik Anadol Studio’s long-term research into creating meditative art based on neurological data.

Finalists and winners will be selected by a panel of leading experts in art, hospitality and technology, including Irini Mirena Papadimitriou, Exhibitions Director at Diriyah Art Futures, Thomas Heyne, Co-Founder and CEO at Scorpios, Dorothy di Stefano, Art Curator and Creative Strategist at Molten Immersive Art, Danielle So, Hong Kong Head of Auction, Modern & Contemporary Art, Phillips, Sebastien Borget, Co-Founder & Global of The Sandbox, SANDchain, President of Blockchain Game Alliance and Co-Founder of Artverse, Jean-Michel Pailhon, Co-Founder and Chief Investment Officer at Grailcapital, Simonida Pavicevic, Co-Founder and Curator at HOFA, Justin Gilanyi, Founder of WhereArt.Works and Curator at SILK, and Matt Zhang, Founder and Managing Partner at Hivemind Capital.

The Digital Art Awards are proudly backed by Lightyear, a subsidiary of Hivemind Digital Group. A full-stack digital culture partner, Lightyear provides infrastructure, liquidity and market expertise, and hands-on delivery for digital ownership and engagement across physical and digital experiences. Lightyear is committed to championing artists and organizations pushing the boundaries of digital culture.

Hashtag: #HOFA #PhillipsX

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending